Company: TVRD
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-111289
Chunk: 33

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 6E
Chunk 33
---
Item 6. Exhibits.

​

​​​​​​​​​​​​​Incorporated by ReferenceExhibitNo.​Description of Exhibit​Form​File No.​Exhibit No.​Date Filed​​​​​​​​​​​2.1‡    Agreement and Plan of Merger and Reorganization, dated as of December 17, 2024, by and among Cara Therapeutics, Inc., CT Convergence Merger Sub, Inc. and Tvardi Therapeutics, Inc.    8-K    001-36279    2.1    December 18, 2024​​​​​​​​​​​3.1​Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​February 7, 2014​​​​​​​​​​​3.2​Amended and Restated Bylaws.​10-Q​001-36279​3.2​November 14, 2024​​​​​​​​​​​3.3​Certificate of Amendment to Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​June 7, 2024​​​​​​​​​​​3.4​Certificate of Amendment to Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​December 30, 2024​​​​​​​​​​​3.5​Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Stock Split Amendment).​8-K​001-36279​3.1​April 15, 2025​​​​​​​​​​​3.6​Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Authorized Shares Amendment).​8-K​001-36279​3.2​April 15, 2025​​​​​​​​​​​3.7​Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Name Change Amendment).​8-K​001-36279​3.3​April 15, 2025​​​​​​​​​​​31.1†​Certification of Chief Executive Officer of Tvardi Therapeutics, Inc